Epidermal Growth Factor Receptor Antagonist [EPC]

Epidermal Growth Factor Receptor Antagonist [EPC] was reported 47292 times

Drugs of the Epidermal Growth Factor Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TRICHOMEGALY 51 1.1591
1 DEPILATION 16 0.4571
2 COLORECTAL CANCER METASTATIC 923 0.3891
3 DERMATITIS ACNEIFORM 1889 0.3101
4 COLORECTAL CANCER RECURRENT 38 0.2946
5 RADIATION MUCOSITIS 44 0.2733
6 SKIN TOXICITY 1257 0.2222
7 RADIATION SKIN INJURY 222 0.1914
8 PARONYCHIA 821 0.1866
9 XERODERMA 46 0.1723
10 HEPATECTOMY 47 0.1502
11 RECTAL CANCER METASTATIC 51 0.1466
12 NAIL BED INFLAMMATION 43 0.1348
13 SEROUS RETINAL DETACHMENT 107 0.1277
14 SQUAMOUS CELL CARCINOMA OF HEAD AND NECK 26 0.1130
15 HYPOMAGNESAEMIA 1426 0.1023
16 COLORECTAL ADENOCARCINOMA 21 0.0938
17 ACNE PUSTULAR 67 0.0817
18 LIVER OPERATION 25 0.0812
19 COLON CANCER METASTATIC 126 0.0781
20 CARCINOEMBRYONIC ANTIGEN INCREASED 150 0.0774
21 MUCOSAL TOXICITY 20 0.0738
22 ADENOCARCINOMA OF COLON 138 0.0736
23 ADENOCARCINOMA METASTATIC 15 0.0728
24 RECTAL ADENOCARCINOMA 44 0.0727
25 XEROSIS 90 0.0727
26 MUCOSAL INFECTION 17 0.0726
27 COLON CANCER RECURRENT 20 0.0725
28 METASTASES TO OVARY 23 0.0721
29 PORTAL VENOUS GAS 25 0.0689
30 GROWTH OF EYELASHES 54 0.0682
31 PHARYNGEAL INFLAMMATION 80 0.0658
32 RASH PUSTULAR 477 0.0654
33 ECTROPION 22 0.0653
34 CARBOHYDRATE ANTIGEN 19-9 INCREASED 33 0.0624
35 GRANULOCYTE COUNT DECREASED 107 0.0577
36 NAIL TOXICITY 17 0.0567
37 CUTANEOUS SYMPTOM 35 0.0512
38 TUMOUR PERFORATION 16 0.0503
39 DERMATITIS INFECTED 24 0.0483
40 BLOOD MAGNESIUM ABNORMAL 26 0.0469
41 PYOGENIC GRANULOMA 21 0.0451
42 MUCOSAL INFLAMMATION 1137 0.0434
43 SKIN CHAPPED 17 0.0421
44 ILEAL PERFORATION 27 0.0407
45 CATHETER RELATED INFECTION 41 0.0405
46 SKIN REACTION 547 0.0388
47 METASTASES TO PERITONEUM 96 0.0380
48 BLOOD MAGNESIUM DECREASED 308 0.0357
49 HYPERTRICHOSIS 66 0.0356
50 PNEUMATOSIS INTESTINALIS 98 0.0343
51 THERAPY PARTIAL RESPONDER 531 0.0340
52 CANCER SURGERY 32 0.0334
53 ONYCHOLYSIS 52 0.0332
54 GASTROINTESTINAL TOXICITY 158 0.0329
55 PULMONARY ARTERY THROMBOSIS 25 0.0326
56 METASTASES TO LIVER 571 0.0325
57 GENE MUTATION 63 0.0318
58 OCULAR TOXICITY 35 0.0317
59 PERIPHERAL SENSORY NEUROPATHY 183 0.0313
60 PUSTULE 73 0.0308
61 ONCOLOGIC COMPLICATION 29 0.0300
62 CHOLINERGIC SYNDROME 19 0.0298
63 METASTATIC SQUAMOUS CELL CARCINOMA 15 0.0294
64 METASTASES TO LUNG 336 0.0291
65 ANASTOMOTIC LEAK 20 0.0288
66 METASTASES TO PELVIS 18 0.0285
67 NODULAR REGENERATIVE HYPERPLASIA 18 0.0280
68 MECHANICAL ILEUS 16 0.0280
69 SUBILEUS 58 0.0278
70 RECTAL PERFORATION 15 0.0278
71 POLYNEUROPATHY 333 0.0278
72 SKIN WOUND 47 0.0276
73 INTRAVASCULAR HAEMOLYSIS 15 0.0268
74 NAIL DYSTROPHY 15 0.0268
75 BLOOD PRESSURE IMMEASURABLE 41 0.0267
76 SKIN FISSURES 523 0.0267
77 SUPERINFECTION BACTERIAL 21 0.0265
78 PROTEUS INFECTION 19 0.0265
79 PERITONEAL DISORDER 17 0.0262
80 INFUSION RELATED HYPERSENSITIVITY REACTION 15 0.0250
81 ANGULAR CHEILITIS 17 0.0246
82 VENA CAVA THROMBOSIS 40 0.0241
83 LYMPHANGIOSIS CARCINOMATOSA 25 0.0240
84 SUBCLAVIAN VEIN THROMBOSIS 27 0.0237
85 HEAD AND NECK CANCER 16 0.0236
86 TUMOUR HAEMORRHAGE 67 0.0235
87 KLEBSIELLA TEST POSITIVE 15 0.0230
88 ENTEROCOLITIS INFECTIOUS 21 0.0228
89 INCORRECT STORAGE OF DRUG 39 0.0226
90 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 525 0.0225
91 AORTIC THROMBOSIS 26 0.0225
92 PERIPHERAL MOTOR NEUROPATHY 31 0.0221
93 COLON CANCER 329 0.0221
94 ABDOMINAL COMPARTMENT SYNDROME 14 0.0220
95 JUGULAR VEIN THROMBOSIS 39 0.0219
96 TUMOUR PAIN 28 0.0212
97 HYPOCALCAEMIA 401 0.0212
98 METASTASES TO LYMPH NODES 143 0.0212
99 ENTEROVESICAL FISTULA 16 0.0211
100 NAIL INFECTION 30 0.0209
101 STOMA SITE HAEMORRHAGE 32 0.0208
102 STOMATITIS 1257 0.0207
103 NEUTROPHIL COUNT DECREASED 840 0.0206
104 RECTAL CANCER 63 0.0205
105 FOLLICULITIS 212 0.0202
106 ONYCHALGIA 20 0.0199
107 MYELOSUPPRESSION 717 0.0199
108 ILEUS 244 0.0196
109 SUPERINFECTION 29 0.0193
110 PELVIC ABSCESS 22 0.0191
111 RECALL PHENOMENON 16 0.0191
112 NAIL DISORDER 167 0.0191
113 INFUSION RELATED REACTION 1252 0.0189
114 EXTRAVASATION 77 0.0187
115 BONE MARROW TOXICITY 22 0.0186
116 HAEMATOTOXICITY 176 0.0185
117 COLON OPERATION 22 0.0184
118 HYPOALBUMINAEMIA 140 0.0180
119 RADIATION INJURY 19 0.0179
120 COLOSTOMY 35 0.0178
121 NEUROTOXICITY 311 0.0177
122 CONJUNCTIVITIS 327 0.0176
123 BILE DUCT OBSTRUCTION 33 0.0174
124 GASTROINTESTINAL STOMA COMPLICATION 27 0.0172
125 FEBRILE BONE MARROW APLASIA 73 0.0172
126 KERATITIS 52 0.0171
127 TUMOUR NECROSIS 18 0.0170
128 DERMATITIS 356 0.0170
129 BLEPHARITIS 67 0.0167
130 HEPATIC LESION 71 0.0164
131 GASTROINTESTINAL PERFORATION 68 0.0163
132 PERFORMANCE STATUS DECREASED 76 0.0163
133 DEVICE RELATED THROMBOSIS 16 0.0162
134 SKIN DISORDER 536 0.0161
135 PNEUMOMEDIASTINUM 29 0.0160
136 MELANOCYTIC NAEVUS 70 0.0159
137 INTERSTITIAL LUNG DISEASE 767 0.0158
138 EMBOLISM ARTERIAL 19 0.0158
139 NEUTROPENIA 2144 0.0158
140 ENTERITIS 99 0.0155
141 THROMBOCYTOPENIC PURPURA 21 0.0154
142 ORAL INTAKE REDUCED 37 0.0153
143 RECTAL TENESMUS 19 0.0152
144 PRINZMETAL ANGINA 15 0.0151
145 NEOPLASM RECURRENCE 51 0.0150
146 BILE DUCT STENOSIS 18 0.0150
147 CHOLANGITIS 92 0.0148
148 ARRHYTHMIA SUPRAVENTRICULAR 16 0.0146
149 RADIATION PNEUMONITIS 31 0.0145
150 PULSE ABSENT 68 0.0143
151 VENOUS THROMBOSIS 56 0.0143
152 OESOPHAGITIS 155 0.0142
153 IMPETIGO 21 0.0141
154 HYPOKALAEMIA 648 0.0140
155 URETERIC OBSTRUCTION 19 0.0139
156 LIVEDO RETICULARIS 29 0.0139
157 STAPHYLOCOCCAL SKIN INFECTION 17 0.0138
158 ADENOCARCINOMA 31 0.0138
159 ACUTE PRERENAL FAILURE 16 0.0138
160 LARGE INTESTINE PERFORATION 96 0.0138
161 FEBRILE NEUTROPENIA 911 0.0137
162 GASTROINTESTINAL NECROSIS 40 0.0137
163 TETANY 25 0.0137
164 BLOOD CULTURE POSITIVE 41 0.0137
165 EXFOLIATIVE RASH 36 0.0137
166 LEUKOPENIA 682 0.0136
167 ENTEROCOLITIS 77 0.0133
168 MALIGNANT NEOPLASM PROGRESSION 1352 0.0132
169 SKIN LESION 358 0.0130
170 PORTAL VEIN THROMBOSIS 42 0.0130
171 BONE MARROW FAILURE 264 0.0130
172 PORTAL HYPERTENSION 40 0.0130
173 LEUKOCYTOCLASTIC VASCULITIS 21 0.0129
174 NEUROPATHY PERIPHERAL 1221 0.0128
175 HYDRONEPHROSIS 96 0.0128
176 STAPHYLOCOCCUS TEST POSITIVE 27 0.0128
177 EMBOLISM 105 0.0126
178 VENOUS THROMBOSIS LIMB 26 0.0126
179 DUODENAL ULCER HAEMORRHAGE 36 0.0126
180 HYPOVOLAEMIC SHOCK 60 0.0125
181 CANCER PAIN 32 0.0125
182 RENAL INFARCT 18 0.0124
183 DEVICE RELATED SEPSIS 25 0.0124
184 PHARYNGEAL HAEMORRHAGE 15 0.0122
185 ANAPHYLACTOID REACTION 50 0.0121
186 ULCERATIVE KERATITIS 33 0.0120
187 OESOPHAGEAL VARICES HAEMORRHAGE 26 0.0120
188 TUMOUR MARKER INCREASED 57 0.0119
189 STAPHYLOCOCCAL BACTERAEMIA 51 0.0117
190 ELECTROLYTE IMBALANCE 136 0.0117
191 HEPATIC NEOPLASM 38 0.0116
192 DEVICE RELATED INFECTION 179 0.0116
193 VENOOCCLUSIVE LIVER DISEASE 57 0.0115
194 CLOSTRIDIAL INFECTION 39 0.0115
195 PERIPHERAL ISCHAEMIA 47 0.0115
196 HYPOPHOSPHATAEMIA 85 0.0115
197 SEBORRHOEIC DERMATITIS 19 0.0115
198 LYMPHADENOPATHY MEDIASTINAL 22 0.0115
199 THROMBOCYTOPENIA 1283 0.0115
200 CEREBRAL ISCHAEMIA 59 0.0115
201 CULTURE URINE POSITIVE 16 0.0114
202 NECROTISING FASCIITIS 40 0.0113
203 CHEILITIS 61 0.0113
204 ODYNOPHAGIA 67 0.0112
205 NEUTROPENIC SEPSIS 80 0.0112
206 SMALL INTESTINAL PERFORATION 21 0.0112
207 HYPERBILIRUBINAEMIA 116 0.0112
208 FAILURE TO THRIVE 58 0.0112
209 CACHEXIA 57 0.0111
210 DISEASE PROGRESSION 1301 0.0110
211 PNEUMONITIS 299 0.0110
212 HEPATIC MASS 21 0.0109
213 STRIDOR 32 0.0109
214 DEHYDRATION 1421 0.0106
215 ABDOMINAL ABSCESS 47 0.0106
216 ANAPHYLACTIC REACTION 585 0.0106
217 METASTASIS 75 0.0105
218 ACCIDENTAL EXPOSURE 43 0.0103
219 SMALL INTESTINAL OBSTRUCTION 127 0.0103
220 RENAL TUBULAR DISORDER 29 0.0103
221 LARYNGEAL OEDEMA 63 0.0102
222 ONYCHOCLASIS 70 0.0102
223 SCAB 116 0.0102
224 BRONCHOSPASM 145 0.0102
225 HYPERPYREXIA 43 0.0101
226 ACNE 770 0.0101
227 PROCTALGIA 65 0.0101
228 ANOREXIA 130 0.0101
229 NASAL ULCER 16 0.0100
230 DECREASED IMMUNE RESPONSIVENESS 98 0.0100
231 HAEMOLYTIC URAEMIC SYNDROME 23 0.0099
232 VARICES OESOPHAGEAL 30 0.0099
233 NEUTROPHIL COUNT ABNORMAL 28 0.0099
234 BLOOD ELECTROLYTES DECREASED 14 0.0098
235 SOFT TISSUE INFECTION 18 0.0098
236 MALNUTRITION 110 0.0098
237 NEOPLASM PROGRESSION 341 0.0098
238 HYPERAMMONAEMIC ENCEPHALOPATHY 17 0.0098
239 RASH 4217 0.0097
240 IGA NEPHROPATHY 16 0.0096
241 PROCTITIS 27 0.0096
242 ANAPHYLACTIC SHOCK 246 0.0095
243 APHTHOUS ULCER 74 0.0095
244 LYMPHOPENIA 134 0.0095
245 INTESTINAL ISCHAEMIA 52 0.0094
246 HAIR GROWTH ABNORMAL 65 0.0094
247 PAPULE 66 0.0094
248 SKIN INJURY 31 0.0093
249 CHAPPED LIPS 40 0.0092
250 EXTREMITY NECROSIS 16 0.0092
251 HYPERAEMIA 18 0.0091
252 INTESTINAL OBSTRUCTION 344 0.0091
253 RASH MACULO-PAPULAR 203 0.0091
254 JAUNDICE CHOLESTATIC 32 0.0090
255 PULMONARY TOXICITY 64 0.0090
256 HYPERAMMONAEMIA 45 0.0090
257 INDURATION 16 0.0090
258 ASPIRATION 98 0.0089
259 NO ADVERSE EFFECT 16 0.0088
260 ARTERIAL THROMBOSIS 17 0.0088
261 PIGMENTATION DISORDER 54 0.0087
262 INTESTINAL PERFORATION 98 0.0087
263 PNEUMONIA ASPIRATION 218 0.0087
264 SKIN HAEMORRHAGE 129 0.0087
265 WHITE BLOOD CELL COUNT DECREASED 934 0.0086
266 PULMONARY EMBOLISM 817 0.0086
267 LARYNGOSPASM 23 0.0085
268 LARGE INTESTINAL OBSTRUCTION 19 0.0085
269 GLOSSITIS 30 0.0084
270 DRY SKIN 1125 0.0084
271 HYPERTHERMIA 64 0.0084
272 DUODENAL ULCER 59 0.0084
273 ORAL DISORDER 61 0.0083
274 ASCITES 244 0.0083
275 ILEUS PARALYTIC 37 0.0083
276 MENINGITIS ASEPTIC 37 0.0082
277 AMYLASE INCREASED 30 0.0081
278 STAPHYLOCOCCAL SEPSIS 40 0.0081
279 ACUTE RESPIRATORY DISTRESS SYNDROME 143 0.0081
280 INGROWING NAIL 19 0.0080
281 METASTASES TO SPINE 27 0.0080
282 SKIN INFECTION 90 0.0080
283 METASTASES TO CENTRAL NERVOUS SYSTEM 103 0.0080
284 GASTROINTESTINAL OBSTRUCTION 19 0.0079
285 DIVERTICULAR PERFORATION 16 0.0078
286 AZOTAEMIA 31 0.0078
287 MULTIPLE-DRUG RESISTANCE 24 0.0077
288 APLASIA 15 0.0077
289 PNEUMONIA STAPHYLOCOCCAL 15 0.0076
290 BLOOD ALBUMIN DECREASED 60 0.0076
291 IMMUNODEFICIENCY 112 0.0075
292 REFUSAL OF TREATMENT BY PATIENT 49 0.0075
293 ILEOSTOMY 19 0.0074
294 ANAEMIA 1418 0.0074
295 IMMUNE THROMBOCYTOPENIA 34 0.0074
296 LIVER ABSCESS 24 0.0074
297 ONYCHOMADESIS 31 0.0074
298 NAIL DISCOLOURATION 29 0.0074
299 APHTHOUS STOMATITIS 17 0.0074
300 SECOND PRIMARY MALIGNANCY 61 0.0073
301 BLOOD CALCIUM DECREASED 82 0.0073
302 SUDDEN DEATH 77 0.0073
303 HYPERNATRAEMIA 36 0.0072
304 GRANULOCYTOPENIA 41 0.0072
305 BLOOD PHOSPHORUS DECREASED 26 0.0071
306 DISSEMINATED INTRAVASCULAR COAGULATION 99 0.0070
307 BRONCHOPNEUMONIA 24 0.0070
308 DYSPHAGIA 661 0.0070
309 CYANOSIS 109 0.0069
310 OXYGEN SATURATION DECREASED 387 0.0069
311 ACUTE CORONARY SYNDROME 57 0.0069
312 DEEP VEIN THROMBOSIS 447 0.0069
313 DISCOURAGEMENT 16 0.0068
314 BACTERAEMIA 81 0.0068
315 COLITIS ISCHAEMIC 46 0.0068
316 HYPOPHAGIA 174 0.0068
317 PULMONARY INFARCTION 16 0.0068
318 GASTROINTESTINAL ULCER 15 0.0068
319 KLEBSIELLA INFECTION 34 0.0067
320 STRESS CARDIOMYOPATHY 39 0.0067
321 SUBCUTANEOUS ABSCESS 32 0.0067
322 PNEUMOTHORAX 105 0.0066
323 PANNICULITIS 16 0.0066
324 CATHETER SITE INFECTION 25 0.0066
325 BLOOD BILIRUBIN INCREASED 178 0.0066
326 HICCUPS 54 0.0066
327 NEPHROTIC SYNDROME 45 0.0066
328 THROMBOTIC THROMBOCYTOPENIC PURPURA 23 0.0065
329 ARTERIOSPASM CORONARY 26 0.0065
330 SEPTIC SHOCK 280 0.0064
331 ANAL HAEMORRHAGE 18 0.0064
332 PLATELET COUNT DECREASED 685 0.0064
333 FAECALOMA 35 0.0064
334 SENSITIVE SKIN 47 0.0064
335 SKIN NECROSIS 33 0.0064
336 OESOPHAGEAL STENOSIS 18 0.0063
337 MYOCARDIAL ISCHAEMIA 72 0.0063
338 ORAL PAIN 141 0.0063
339 THROMBOPHLEBITIS 22 0.0063
340 RESPIRATORY DISTRESS 173 0.0063
341 ABDOMINAL INFECTION 16 0.0063
342 OESOPHAGEAL ULCER 24 0.0062
343 BLOOD ALKALINE PHOSPHATASE INCREASED 155 0.0062
344 PHYSICAL DECONDITIONING 16 0.0062
345 SEPSIS 692 0.0062
346 DECREASED APPETITE 1432 0.0062
347 PROTEINURIA 117 0.0061
348 HEPATIC FAILURE 185 0.0061
349 HYPOXIA 216 0.0061
350 MOUTH ULCERATION 129 0.0061
351 PURPURA 54 0.0061
352 LOCALISED OEDEMA 28 0.0060
353 METASTATIC NEOPLASM 26 0.0060
354 TUMOUR LYSIS SYNDROME 53 0.0060
355 TYPE I HYPERSENSITIVITY 21 0.0060
356 CHILLS 699 0.0060
357 HYPONATRAEMIA 335 0.0059
358 NECROSIS 33 0.0059
359 TONGUE ULCERATION 20 0.0059
360 SKIN EROSION 19 0.0059
361 MACULAR OEDEMA 33 0.0059
362 SKIN WRINKLING 16 0.0059
363 CARDIO-RESPIRATORY ARREST 245 0.0059
364 LUNG NEOPLASM 25 0.0058
365 BLOOD CHLORIDE DECREASED 15 0.0058
366 APHAGIA 28 0.0058
367 HYPOVOLAEMIA 34 0.0058
368 COLORECTAL CANCER 277 0.0058
369 GENERAL PHYSICAL HEALTH DETERIORATION 668 0.0058
370 DERMATITIS ALLERGIC 72 0.0057
371 INFUSION SITE REACTION 17 0.0057
372 PYELONEPHRITIS 49 0.0056
373 HEPATIC FUNCTION ABNORMAL 211 0.0056
374 PHOTOSENSITIVITY REACTION 93 0.0056
375 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 190 0.0056
376 METASTASES TO BONE 92 0.0056
377 DIARRHOEA 3612 0.0056
378 LIP PAIN 16 0.0056
379 HEPATIC NECROSIS 21 0.0056
380 SKIN ATROPHY 32 0.0056
381 LUNG INFILTRATION 49 0.0055
382 PAIN OF SKIN 149 0.0055
383 HYPOTENSION 1109 0.0055
384 BLOOD SODIUM DECREASED 104 0.0055
385 CANDIDIASIS 22 0.0055
386 PHLEBITIS 28 0.0055
387 GENERALISED ERYTHEMA 31 0.0054
388 LUNG INFECTION 84 0.0054
389 RECURRENT CANCER 22 0.0054
390 WOUND INFECTION 59 0.0054
391 TACHYPNOEA 73 0.0054
392 METABOLIC ENCEPHALOPATHY 16 0.0053
393 RESPIRATORY FAILURE 388 0.0053
394 ASPARTATE AMINOTRANSFERASE INCREASED 281 0.0053
395 EMBOLISM VENOUS 16 0.0053
396 SKIN ULCER 136 0.0053
397 DUODENITIS 16 0.0052
398 BLOOD PRESSURE DECREASED 346 0.0052
399 ERYTHEMA 1060 0.0052
400 PURULENT DISCHARGE 22 0.0051
401 INFUSION SITE EXTRAVASATION 32 0.0051
402 SUPRAVENTRICULAR TACHYCARDIA 49 0.0051
403 COLITIS 194 0.0051
404 JAUNDICE 137 0.0051
405 INTERCEPTED PRODUCT ADMINISTRATION ERROR 39 0.0051
406 OESOPHAGEAL PAIN 20 0.0051
407 CONJUNCTIVAL HYPERAEMIA 18 0.0050
408 BLOOD POTASSIUM DECREASED 150 0.0050
409 ERYSIPELAS 25 0.0050
410 SQUAMOUS CELL CARCINOMA OF SKIN 30 0.0050
411 ATELECTASIS 48 0.0050
412 SINUS TACHYCARDIA 70 0.0049
413 RETINAL DETACHMENT 45 0.0049
414 SKIN TIGHTNESS 23 0.0049
415 SUSPECTED OFF LABEL USE 22 0.0049
416 STAPHYLOCOCCAL INFECTION 160 0.0048
417 ALANINE AMINOTRANSFERASE INCREASED 295 0.0048
418 DERMATITIS EXFOLIATIVE 24 0.0048
419 PNEUMONIA BACTERIAL 44 0.0048
420 DRUG RESISTANCE 123 0.0048
421 SKIN HYPERPIGMENTATION 41 0.0048
422 HYPERSENSITIVITY 885 0.0048
423 RASH VESICULAR 23 0.0048
424 LYMPHOCYTE COUNT DECREASED 84 0.0047
425 RASH GENERALISED 123 0.0047
426 HYPERTRANSAMINASAEMIA 33 0.0047
427 PYREXIA 1640 0.0047
428 RENAL FAILURE ACUTE 201 0.0047
429 ERYTHEMA MULTIFORME 44 0.0047
430 HAEMOLYTIC ANAEMIA 42 0.0047
431 MOUTH HAEMORRHAGE 34 0.0046
432 HYPERKALAEMIA 162 0.0046
433 NON-SMALL CELL LUNG CANCER 22 0.0046
434 LEUKOCYTOSIS 83 0.0046
435 CIRCULATORY COLLAPSE 78 0.0046
436 THROMBOSIS IN DEVICE 15 0.0046
437 LIPASE INCREASED 35 0.0046
438 TOXIC SKIN ERUPTION 46 0.0046
439 PROTEIN TOTAL DECREASED 17 0.0045
440 OBSTRUCTION 18 0.0045
441 CEREBRAL INFARCTION 109 0.0045
442 PLEURAL EFFUSION 271 0.0044
443 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
444 ABDOMINAL ADHESIONS 14 0.0044
445 RASH PAPULAR 99 0.0044
446 PERITONITIS 91 0.0044
447 AUTOIMMUNE HAEMOLYTIC ANAEMIA 15 0.0044
448 FUNCTIONAL GASTROINTESTINAL DISORDER 15 0.0043
449 VOMITING 2034 0.0043
450 SKIN EXFOLIATION 363 0.0043
451 FACE OEDEMA 72 0.0043
452 ANAL ABSCESS 23 0.0043
453 HEPATOTOXICITY 95 0.0043
454 PANCYTOPENIA 238 0.0043
455 HAEMOGLOBIN DECREASED 434 0.0042
456 VASCULAR DEVICE INFECTION 19 0.0042
457 PULMONARY MASS 62 0.0042
458 DERMATITIS BULLOUS 30 0.0041
459 ATRIAL FLUTTER 33 0.0041
460 POST PROCEDURAL HAEMORRHAGE 48 0.0041
461 TONGUE DISCOLOURATION 18 0.0041
462 FEMORAL NECK FRACTURE 21 0.0041
463 ENDOCARDITIS 21 0.0041
464 FEEDING DISORDER 83 0.0041
465 PULMONARY HAEMORRHAGE 32 0.0041
466 PROCEDURAL HAEMORRHAGE 16 0.0041
467 RESPIRATORY ARREST 112 0.0041
468 TACHYCARDIA 360 0.0040
469 EPISTAXIS 300 0.0040
470 MELAENA 88 0.0040
471 BLOOD LACTIC ACID INCREASED 21 0.0040
472 HAEMATOCRIT DECREASED 79 0.0040
473 TEMPERATURE INTOLERANCE 41 0.0040
474 ACUTE MYOCARDIAL INFARCTION 116 0.0039
475 MULTI-ORGAN FAILURE 68 0.0039
476 BODY TEMPERATURE INCREASED 80 0.0039
477 PULMONARY FIBROSIS 75 0.0039
478 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
479 ABDOMINAL PAIN 901 0.0039
480 RASH ERYTHEMATOUS 185 0.0039
481 ASTHENIA 1453 0.0039
482 HEPATIC ENCEPHALOPATHY 36 0.0039
483 HAEMOPTYSIS 107 0.0038
484 PETECHIAE 40 0.0038
485 BLOOD CREATININE INCREASED 250 0.0038
486 FACIAL PAIN 34 0.0038
487 HAEMOLYSIS 29 0.0038
488 FLUSHING 380 0.0037
489 EYELID OEDEMA 43 0.0037
490 TRANSAMINASES INCREASED 82 0.0037
491 TRISMUS 19 0.0037
492 ASPHYXIA 30 0.0037
493 ACIDOSIS 28 0.0037
494 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
495 HYPERCALCAEMIA 45 0.0036
496 UNRESPONSIVE TO STIMULI 94 0.0036
497 GASTROENTERITIS 53 0.0036
498 SPINAL COMPRESSION FRACTURE 30 0.0036
499 AORTIC DISSECTION 15 0.0036
500 EATING DISORDER 77 0.0036
501 MENTAL STATUS CHANGES 100 0.0036
502 RASH PRURITIC 195 0.0036
503 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
504 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
505 ANAL FISTULA 19 0.0036
506 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
507 CANDIDA INFECTION 60 0.0035
508 CHOLESTASIS 68 0.0035
509 POST PROCEDURAL COMPLICATION 68 0.0035
510 LIP DRY 32 0.0035
511 HYPERTENSIVE CRISIS 39 0.0035
512 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
513 CARDIOTOXICITY 31 0.0035
514 BLOOD LACTATE DEHYDROGENASE INCREASED 55 0.0035
515 RENAL TUBULAR NECROSIS 34 0.0035
516 CARDIAC FAILURE ACUTE 23 0.0034
517 HYPERKERATOSIS 19 0.0034
518 HYPERGLYCAEMIA 125 0.0034
519 ORGANISING PNEUMONIA 17 0.0034
520 HAEMATURIA 117 0.0034
521 PROTEIN URINE PRESENT 17 0.0034
522 HERPES SIMPLEX 22 0.0034
523 ABSCESS 54 0.0034
524 FISTULA 38 0.0034
525 ACUTE RESPIRATORY FAILURE 65 0.0034
526 COLECTOMY 19 0.0034
527 WEIGHT DECREASED 938 0.0034
528 UROSEPSIS 31 0.0034
529 ANAL FISSURE 18 0.0034
530 C-REACTIVE PROTEIN INCREASED 122 0.0033
531 NEUTROPHILIA 19 0.0033
532 DRUG ERUPTION 59 0.0033
533 HAEMATEMESIS 84 0.0033
534 PERIORBITAL OEDEMA 17 0.0033
535 METABOLIC DISORDER 19 0.0033
536 RESPIRATORY RATE INCREASED 29 0.0033
537 HEPATOMEGALY 32 0.0033
538 MUCOUS STOOLS 16 0.0032
539 SYNCOPE 323 0.0032
540 SHOCK 74 0.0032
541 ANORECTAL DISCOMFORT 17 0.0032
542 RECTAL HAEMORRHAGE 137 0.0032
543 CARDIAC ARREST 263 0.0032
544 ALTERED STATE OF CONSCIOUSNESS 69 0.0032
545 EYE DISCHARGE 33 0.0032
546 THROMBOSIS 255 0.0032
547 CARDIAC TAMPONADE 15 0.0032
548 FURUNCLE 25 0.0032
549 ATRIAL FIBRILLATION 306 0.0031
550 NAUSEA 2482 0.0031
551 DYSPNOEA 1775 0.0031
552 PRURITUS 1205 0.0031
553 HERPES VIRUS INFECTION 18 0.0031
554 NEPHROPATHY TOXIC 35 0.0031
555 BACTERIAL INFECTION 58 0.0031
556 VENTRICULAR TACHYCARDIA 51 0.0031
557 INFECTION 447 0.0031
558 BLOOD PRESSURE SYSTOLIC DECREASED 14 0.0031
559 THROAT TIGHTNESS 83 0.0031
560 GASTRIC ULCER HAEMORRHAGE 17 0.0031
561 LIVER DISORDER 136 0.0031
562 MYOCARDITIS 35 0.0031
563 ANGINA PECTORIS 87 0.0030
564 CHOLECYSTITIS 36 0.0030
565 OFF LABEL USE 2628 0.0030
566 HEPATITIS CHOLESTATIC 18 0.0030
567 SPEECH DISORDER 156 0.0030
568 LYMPHADENOPATHY 105 0.0030
569 PULMONARY THROMBOSIS 32 0.0029
570 INFARCTION 20 0.0029
571 VASCULITIS 34 0.0029
572 ESCHERICHIA INFECTION 24 0.0029
573 PRURITUS GENERALISED 63 0.0029
574 HYPERTRIGLYCERIDAEMIA 17 0.0029
575 SPLENOMEGALY 34 0.0029
576 TONGUE DISORDER 21 0.0029
577 CELLULITIS 146 0.0029
578 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82 0.0029
579 GASTRIC ULCER 55 0.0029
580 TENDERNESS 30 0.0029
581 NASAL DRYNESS 18 0.0029
582 PALLOR 78 0.0029
583 ACUTE KIDNEY INJURY 437 0.0029
584 LOSS OF CONSCIOUSNESS 362 0.0028
585 PHARYNGOLARYNGEAL PAIN 15 0.0028
586 PLATELET COUNT ABNORMAL 17 0.0028
587 ENCEPHALOPATHY 69 0.0028
588 COMPRESSION FRACTURE 15 0.0028
589 GASTROINTESTINAL INFECTION 25 0.0028
590 DIARRHOEA HAEMORRHAGIC 26 0.0028
591 RENAL CYST 22 0.0028
592 URINARY INCONTINENCE 82 0.0028
593 SQUAMOUS CELL CARCINOMA 26 0.0028
594 TROPONIN INCREASED 21 0.0028
595 UPPER GASTROINTESTINAL HAEMORRHAGE 46 0.0027
596 RENAL FAILURE 363 0.0027
597 SPINAL PAIN 32 0.0027
598 PERICARDIAL EFFUSION 63 0.0027
599 PANCREATITIS ACUTE 61 0.0027
600 SKIN BURNING SENSATION 194 0.0027
601 APNOEA 21 0.0027
602 PLEURISY 16 0.0027
603 LEFT VENTRICULAR DYSFUNCTION 18 0.0027
604 SUNBURN 20 0.0027
605 PNEUMONIA 865 0.0027
606 HEARING IMPAIRED 16 0.0027
607 LIVER INJURY 65 0.0026
608 DRUG TOXICITY 36 0.0026
609 CHEST DISCOMFORT 270 0.0026
610 SECRETION DISCHARGE 33 0.0026
611 BLOOD UREA INCREASED 44 0.0026
612 ADVERSE EVENT 242 0.0026
613 SALIVARY HYPERSECRETION 26 0.0026
614 HEMIPARESIS 44 0.0026
615 SKIN LACERATION 28 0.0026
616 PSEUDOMONAS INFECTION 22 0.0026
617 INFLAMMATION 131 0.0025
618 DELIRIUM 88 0.0025
619 BLISTER 142 0.0025
620 NASAL DISCOMFORT 20 0.0025
621 URINARY RETENTION 84 0.0025
622 POSTOPERATIVE WOUND INFECTION 17 0.0025
623 EJECTION FRACTION DECREASED 39 0.0025
624 HAEMOGLOBIN ABNORMAL 16 0.0025
625 SKIN DISCOLOURATION 114 0.0025
626 AGRANULOCYTOSIS 46 0.0025
627 HYPOTHERMIA 25 0.0025
628 FEELING HOT 151 0.0025
629 DECUBITUS ULCER 20 0.0025
630 ULCER 39 0.0024
631 NEOPLASM 28 0.0024
632 CONSTIPATION 531 0.0024
633 HYPERAESTHESIA 20 0.0024
634 HEPATIC CYTOLYSIS 31 0.0024
635 HOSPICE CARE 24 0.0024
636 STEVENS-JOHNSON SYNDROME 54 0.0024
637 OBSTRUCTIVE AIRWAYS DISORDER 27 0.0024
638 OLIGURIA 15 0.0024
639 LACRIMATION INCREASED 73 0.0024
640 HEPATIC STEATOSIS 45 0.0024
641 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23 0.0024
642 LUNG DISORDER 118 0.0024
643 CARDIAC FAILURE 193 0.0024
644 MENINGITIS 16 0.0024
645 DEATH 2064 0.0024
646 COLD SWEAT 42 0.0024
647 ORAL CANDIDIASIS 31 0.0024
648 WHITE BLOOD CELL COUNT ABNORMAL 15 0.0023
649 COAGULOPATHY 39 0.0023
650 PHARYNGEAL OEDEMA 36 0.0023
651 PHARYNGITIS 29 0.0023
652 OCCUPATIONAL EXPOSURE TO PRODUCT 15 0.0023
653 URINARY TRACT INFECTION 394 0.0023
654 RENAL IMPAIRMENT 194 0.0023
655 PRODUCT STORAGE ERROR 202 0.0023
656 ALOPECIA 453 0.0023
657 EYE INFLAMMATION 22 0.0023
658 SKIN SWELLING 20 0.0023
659 ORAL DISCOMFORT 32 0.0023
660 NO THERAPEUTIC RESPONSE 28 0.0023
661 EXTRASYSTOLES 16 0.0023
662 EMPHYSEMA 23 0.0023
663 FATIGUE 1771 0.0023
664 GENERALISED OEDEMA 28 0.0023
665 EPILEPSY 69 0.0023
666 VENTRICULAR FIBRILLATION 25 0.0022
667 DEPRESSED LEVEL OF CONSCIOUSNESS 89 0.0022
668 NEPHROPATHY 21 0.0022
669 FLANK PAIN 21 0.0022
670 DYSPHONIA 131 0.0022
671 CARDIOMYOPATHY 33 0.0022
672 FEELING COLD 62 0.0022
673 COMA 106 0.0022
674 PLATELET COUNT INCREASED 29 0.0022
675 HYPERHIDROSIS 286 0.0022
676 URTICARIA 371 0.0022
677 GENERAL PHYSICAL CONDITION ABNORMAL 15 0.0022
678 HYPERTENSION 468 0.0022
679 ARRHYTHMIA 104 0.0022
680 INCONTINENCE 23 0.0022
681 INTERNATIONAL NORMALISED RATIO INCREASED 62 0.0022
682 GASTROINTESTINAL INFLAMMATION 17 0.0022
683 GRAND MAL CONVULSION 20 0.0022
684 BLOOD CREATINE PHOSPHOKINASE INCREASED 62 0.0022
685 DUODENAL ULCER PERFORATION 16 0.0021
686 SURGERY 126 0.0021
687 NEOPLASM MALIGNANT 143 0.0021
688 OEDEMA 116 0.0021
689 CHEST PAIN 395 0.0021
690 GASTRITIS 56 0.0021
691 ORTHOSTATIC HYPOTENSION 37 0.0021
692 HAEMORRHAGE 222 0.0021
693 OROPHARYNGEAL DISCOMFORT 19 0.0021
694 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
695 WHITE BLOOD CELL COUNT INCREASED 80 0.0021
696 DRY MOUTH 169 0.0021
697 DYSGEUSIA 154 0.0021
698 DRY EYE 103 0.0021
699 LIVER FUNCTION TEST ABNORMAL 60 0.0021
700 MALAISE 900 0.0021
701 NEUTROPHIL COUNT INCREASED 21 0.0020
702 STATUS EPILEPTICUS 23 0.0020
703 ADVERSE REACTION 27 0.0020
704 PARAESTHESIA 320 0.0020
705 VENTRICULAR EXTRASYSTOLES 21 0.0020
706 CONVULSION 115 0.0020
707 ANAL INCONTINENCE 18 0.0020
708 BLOOD DISORDER 16 0.0020
709 CYTOKINE RELEASE SYNDROME 40 0.0020
710 UVEITIS 27 0.0020
711 DEVICE OCCLUSION 28 0.0020
712 LOCALISED INFECTION 48 0.0020
713 BEDRIDDEN 26 0.0020
714 DISEASE RECURRENCE 94 0.0020
715 HEPATOCELLULAR INJURY 28 0.0020
716 WOUND 55 0.0020
717 SHOCK HAEMORRHAGIC 16 0.0020
718 THROMBOTIC MICROANGIOPATHY 19 0.0019
719 TASTE DISORDER 39 0.0019
720 HAEMORRHAGIC STROKE 15 0.0019
721 GINGIVAL BLEEDING 26 0.0019
722 BLOOD PRESSURE DIASTOLIC DECREASED 14 0.0019
723 SWELLING FACE 123 0.0019
724 RASH MACULAR 66 0.0019
725 OEDEMA PERIPHERAL 227 0.0019
726 PULMONARY OEDEMA 83 0.0019
727 BLOOD THYROID STIMULATING HORMONE INCREASED 17 0.0018
728 HAEMORRHOIDS 36 0.0018
729 DISORIENTATION 73 0.0018
730 DEAFNESS 48 0.0018
731 GASTRIC HAEMORRHAGE 21 0.0018
732 SWOLLEN TONGUE 57 0.0018
733 BRAIN OEDEMA 23 0.0018
734 PERIPHERAL COLDNESS 25 0.0018
735 HAIR DISORDER 15 0.0018
736 GASTROINTESTINAL HAEMORRHAGE 152 0.0018
737 SUBDURAL HAEMATOMA 26 0.0018
738 PRESYNCOPE 44 0.0018
739 CYTOPENIA 22 0.0018
740 LABORATORY TEST ABNORMAL 53 0.0018
741 ORAL HERPES 35 0.0018
742 EYE INFECTION 20 0.0018
743 ANURIA 15 0.0017
744 FULL BLOOD COUNT DECREASED 35 0.0017
745 GASTROINTESTINAL PAIN 19 0.0017
746 SKIN IRRITATION 79 0.0017
747 PANCREATITIS 91 0.0017
748 MALIGNANT MELANOMA 23 0.0017
749 RED BLOOD CELL COUNT DECREASED 49 0.0017
750 BLOOD PRESSURE ABNORMAL 34 0.0017
751 WHEEZING 101 0.0017
752 IMMUNOSUPPRESSION 15 0.0017
753 OSTEONECROSIS OF JAW 42 0.0017
754 OCULAR HYPERAEMIA 80 0.0017
755 LIVER FUNCTION TEST INCREASED 36 0.0017
756 CHOLECYSTECTOMY 19 0.0017
757 BURNING SENSATION 116 0.0017
758 HYPOGLYCAEMIA 80 0.0016
759 DRUG ADMINISTRATION ERROR 50 0.0016
760 METABOLIC ACIDOSIS 52 0.0016
761 DISCOMFORT 98 0.0016
762 BACK PAIN 373 0.0016
763 HEART RATE INCREASED 159 0.0016
764 HEPATITIS 41 0.0016
765 TRANSIENT ISCHAEMIC ATTACK 54 0.0016
766 HEPATIC CIRRHOSIS 30 0.0016
767 FRACTURE 30 0.0016
768 BLOOD URINE PRESENT 30 0.0016
769 THERAPY NON-RESPONDER 71 0.0016
770 MASS 22 0.0016
771 ISCHAEMIC STROKE 28 0.0016
772 EYE IRRITATION 90 0.0016
773 DRUG-INDUCED LIVER INJURY 49 0.0016
774 MUSCULOSKELETAL CHEST PAIN 24 0.0015
775 RENAL DISORDER 72 0.0015
776 BLOOD POTASSIUM INCREASED 25 0.0015
777 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 109 0.0015
778 ILL-DEFINED DISORDER 93 0.0015
779 AGEUSIA 38 0.0015
780 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
781 MUSCULOSKELETAL PAIN 79 0.0015
782 GASTROINTESTINAL DISORDER 135 0.0015
783 LIP SWELLING 50 0.0015
784 IMPAIRED HEALING 49 0.0015
785 EYE DISORDER 49 0.0015
786 MICTURITION URGENCY 17 0.0015
787 HEART RATE DECREASED 52 0.0015
788 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
789 CONFUSIONAL STATE 238 0.0015
790 RESPIRATORY DISORDER 44 0.0015
791 BRADYCARDIA 78 0.0015
792 ABDOMINAL PAIN LOWER 37 0.0015
793 APHASIA 44 0.0015
794 TOXICITY TO VARIOUS AGENTS 243 0.0014
795 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
796 DYSARTHRIA 54 0.0014
797 KIDNEY INFECTION 28 0.0014
798 DYSURIA 52 0.0014
799 RETCHING 30 0.0014
800 OROPHARYNGEAL PAIN 130 0.0014
801 LETHARGY 80 0.0014
802 ABDOMINAL DISTENSION 145 0.0014
803 HYPOTHYROIDISM 44 0.0014
804 HEPATIC ENZYME INCREASED 93 0.0014
805 FAECES DISCOLOURED 29 0.0013
806 MUSCULAR WEAKNESS 152 0.0013
807 HERPES ZOSTER 76 0.0013
808 PRODUCTIVE COUGH 63 0.0013
809 MYOCARDIAL INFARCTION 230 0.0013
810 EYE SWELLING 49 0.0013
811 DERMATITIS CONTACT 15 0.0013
812 CHOLELITHIASIS 43 0.0013
813 RESPIRATORY DEPRESSION 16 0.0013
814 DRUG INTOLERANCE 126 0.0013
815 NODULE 17 0.0013
816 INTERCEPTED PRODUCT PREPARATION ERROR 16 0.0013
817 ECZEMA 68 0.0013
818 MEDICATION ERROR 72 0.0013
819 GLOSSODYNIA 29 0.0013
820 COUGH 357 0.0013
821 HAIR TEXTURE ABNORMAL 17 0.0013
822 PARALYSIS 18 0.0013
823 CARDIOGENIC SHOCK 18 0.0013
824 MUSCLE RIGIDITY 15 0.0013
825 LIMB INJURY 34 0.0013
826 HEPATITIS C 15 0.0012
827 CHROMATURIA 28 0.0012
828 ADRENAL INSUFFICIENCY 15 0.0012
829 BLOOD PRESSURE INCREASED 188 0.0012
830 APHONIA 17 0.0012
831 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 63 0.0012
832 HAEMORRHAGE INTRACRANIAL 18 0.0012
833 FUNGAL INFECTION 40 0.0012
834 QUALITY OF LIFE DECREASED 16 0.0012
835 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
836 CARDIOVASCULAR DISORDER 30 0.0012
837 NECK PAIN 66 0.0012
838 HAEMATOCHEZIA 65 0.0012
839 ABDOMINAL PAIN UPPER 241 0.0012
840 SEIZURE 135 0.0012
841 NEURALGIA 28 0.0012
842 CEREBRAL HAEMORRHAGE 41 0.0011
843 BLOOD TEST ABNORMAL 16 0.0011
844 HYPOAESTHESIA 170 0.0011
845 TREATMENT FAILURE 94 0.0011
846 TREMOR 188 0.0011
847 PERICARDITIS 19 0.0011
848 HYPOAESTHESIA ORAL 17 0.0011
849 ILLNESS 116 0.0011
850 DIVERTICULITIS 31 0.0011
851 PAIN 684 0.0011
852 SCAR 19 0.0011
853 CEREBROVASCULAR ACCIDENT 188 0.0011
854 PARAESTHESIA ORAL 16 0.0011
855 ACUTE HEPATIC FAILURE 15 0.0011
856 PALPITATIONS 127 0.0011
857 RESPIRATORY TRACT INFECTION 28 0.0011
858 DIZZINESS 533 0.0011
859 DYSPNOEA EXERTIONAL 40 0.0011
860 BONE PAIN 62 0.0011
861 THROAT IRRITATION 47 0.0010
862 EYE PRURITUS 35 0.0010
863 RESTLESSNESS 38 0.0010
864 HERNIA 20 0.0010
865 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
866 NERVOUS SYSTEM DISORDER 32 0.0010
867 VERTIGO 62 0.0010
868 CYSTITIS 32 0.0010
869 SWELLING 94 0.0010
870 VISUAL ACUITY REDUCED 33 0.0010
871 RHABDOMYOLYSIS 41 0.0010
872 ADVERSE DRUG REACTION 88 0.0010
873 THERAPEUTIC RESPONSE DECREASED 59 0.0010
874 EOSINOPHILIA 17 0.0010
875 DRUG EFFECT INCOMPLETE 35 0.0010
876 DIPLOPIA 25 0.0010
877 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
878 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
879 CONDITION AGGRAVATED 278 0.0009
880 HYPOACUSIS 39 0.0009
881 ACUTE MYELOID LEUKAEMIA 14 0.0009
882 VISION BLURRED 121 0.0009
883 SOMNOLENCE 177 0.0009
884 CHOKING 17 0.0009
885 MENTAL IMPAIRMENT 21 0.0009
886 DYSPEPSIA 85 0.0009
887 LOCAL SWELLING 15 0.0009
888 PHOTOPHOBIA 16 0.0008
889 THERAPY INTERRUPTED 60 0.0008
890 PELVIC PAIN 15 0.0008
891 BONE DISORDER 15 0.0008
892 BLINDNESS 33 0.0008
893 PRODUCT USE IN UNAPPROVED INDICATION 200 0.0008
894 CARDIAC DISORDER 75 0.0008
895 PROCEDURAL PAIN 22 0.0008
896 POLLAKIURIA 33 0.0008
897 PAIN IN EXTREMITY 232 0.0008
898 CATARACT 46 0.0008
899 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
900 COVID-19 132 0.0008
901 COGNITIVE DISORDER 35 0.0007
902 MUSCLE SPASMS 137 0.0007
903 NEPHROLITHIASIS 34 0.0007
904 HYPERSOMNIA 21 0.0007
905 BRONCHITIS 54 0.0007
906 FALL 238 0.0007
907 UNEVALUABLE EVENT 54 0.0007
908 LUNG NEOPLASM MALIGNANT 29 0.0007
909 FREQUENT BOWEL MOVEMENTS 19 0.0007
910 MYALGIA 119 0.0007
911 SKIN CANCER 15 0.0007
912 HEADACHE 425 0.0007
913 MENTAL DISORDER 29 0.0007
914 CORONARY ARTERY DISEASE 20 0.0007
915 HOT FLUSH 49 0.0006
916 DEMENTIA 18 0.0006
917 AGITATION 47 0.0006
918 TINNITUS 29 0.0006
919 VIRAL INFECTION 21 0.0006
920 FLATULENCE 35 0.0006
921 GAIT DISTURBANCE 118 0.0006
922 DYSSTASIA 18 0.0006
923 ANGIOEDEMA 27 0.0006
924 PERIPHERAL SWELLING 94 0.0006
925 PRODUCT USE ISSUE 113 0.0006
926 VAGINAL HAEMORRHAGE 26 0.0006
927 CARDIAC FAILURE CONGESTIVE 48 0.0006
928 DEPRESSED MOOD 31 0.0006
929 ABDOMINAL DISCOMFORT 98 0.0006
930 HAEMATOMA 15 0.0006
931 INSOMNIA 153 0.0006
932 GAIT INABILITY 19 0.0006
933 DRUG INTERACTION 90 0.0006
934 ABASIA 14 0.0006
935 VISUAL IMPAIRMENT 70 0.0006
936 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
937 ANXIETY 160 0.0006
938 EYE PAIN 31 0.0005
939 FEMUR FRACTURE 17 0.0005
940 RENAL INJURY 16 0.0005
941 DIABETES MELLITUS 41 0.0005
942 HEAD INJURY 17 0.0005
943 UNDERDOSE 39 0.0005
944 RHINORRHOEA 34 0.0005
945 LACTIC ACIDOSIS 17 0.0005
946 INFLUENZA 58 0.0005
947 CONTUSION 50 0.0005
948 HOSPITALISATION 77 0.0005
949 MOBILITY DECREASED 36 0.0005
950 DEPRESSION 114 0.0005
951 HIP FRACTURE 16 0.0005
952 TREATMENT NONCOMPLIANCE 27 0.0005
953 FLUID RETENTION 25 0.0005
954 EMOTIONAL DISORDER 15 0.0005
955 ARTHRALGIA 188 0.0005
956 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
957 ACCIDENTAL OVERDOSE 16 0.0004
958 DRUG INEFFECTIVE 557 0.0004
959 FEELING ABNORMAL 101 0.0004
960 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
961 DEVICE DISLOCATION 18 0.0004
962 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
963 DYSKINESIA 16 0.0004
964 NASAL CONGESTION 23 0.0004
965 BLOOD GLUCOSE INCREASED 73 0.0004
966 ABNORMAL BEHAVIOUR 15 0.0004
967 ACCIDENTAL EXPOSURE TO PRODUCT 37 0.0004
968 NASOPHARYNGITIS 63 0.0003
969 INFLUENZA LIKE ILLNESS 28 0.0003
970 WEIGHT INCREASED 75 0.0003
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
972 ARTHRITIS 25 0.0003
973 DRUG DOSE OMISSION 51 0.0003
974 JOINT SWELLING 36 0.0003
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
976 MEMORY IMPAIRMENT 40 0.0003
977 BALANCE DISORDER 24 0.0003
978 MUSCULOSKELETAL STIFFNESS 24 0.0003
979 MIGRAINE 26 0.0003
980 INJURY 19 0.0003
981 SLEEP DISORDER 19 0.0003
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
983 SINUSITIS 26 0.0003
984 AMNESIA 16 0.0002
985 OVERDOSE 53 0.0002
986 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
987 HALLUCINATION 17 0.0002
988 CHRONIC KIDNEY DISEASE 17 0.0002
989 ASTHMA 24 0.0002
990 NO ADVERSE EVENT 30 0.0002
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
992 INCORRECT DOSE ADMINISTERED 32 0.0001
993 PRODUCT DOSE OMISSION ISSUE 33 0.0001